A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study



Status:Terminated
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - Any
Updated:9/29/2018
Start Date:January 2016

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Cervix cancer is a major global health concern. A way to screen and immediately treat
precancerous lesions (Screen-and-Treat) is greatly needed. Developed by MobileOCT, polarized
difference imaging and conventional imaging are used to identify suspicious lesions. We aim
to compare this non-invasive method with colposcopy. Patients at the Dickens Clinic will have
3-5 minutes of non-invasive imaging before colposcopy. Pathology will be compared both to
colposcopy impression versus MobileOCT.


Inclusion Criteria:

- Subjects capable of giving informed consent or have an acceptable surrogate capable of
giving consent on subjects behalf.

- Subjects are 18 years of age or older

- Subjects are scheduled for colposcopy clinic based on screening with abnormal pap
smear or have repeat colposcopy indicated for specific clinical indications, based off
of American Society of Cosposcopy and Cytology.

- Subjects are women.

Exclusion Criteria:

- Pregnancy.

- Males (males do not have a cervix and thus cannot undergo colposcopy).
We found this trial at
1
site
Abramson Cancer Center of the University of Pennsylvania
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Charles Hummel, MD, PhD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials